Back to resultsSelegiline in Treatment of Cocaine Dependence - 2
Primary Purpose
Cocaine-Related Disorders
Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Selegiline
Sponsored by
About this trial
This is an interventional treatment trial for Cocaine-Related Disorders focused on measuring Cocaine Dependence, Selegiline
Eligibility Criteria
Please contact site for information.
Sites / Locations
- PDVAMC Treatment Research Center
Outcomes
Primary Outcome Measures
Retention
Cocaine use
Cocaine craving
Secondary Outcome Measures
Full Information
NCT ID
NCT00000188
First Posted
September 20, 1999
Last Updated
May 26, 2015
Sponsor
University of Pennsylvania
Collaborators
National Institute on Drug Abuse (NIDA)
1. Study Identification
Unique Protocol Identification Number
NCT00000188
Brief Title
Selegiline in Treatment of Cocaine Dependence - 2
Official Title
Selegiline in Treatment of Cocaine Dependence
Study Type
Interventional
2. Study Status
Record Verification Date
May 2015
Overall Recruitment Status
Completed
Study Start Date
September 1994 (undefined)
Primary Completion Date
October 1995 (Actual)
Study Completion Date
October 1995 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Pennsylvania
Collaborators
National Institute on Drug Abuse (NIDA)
4. Oversight
5. Study Description
Brief Summary
The purpose of this study is to assess selegiline as a pharmacotherapy for cocaine dependence.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cocaine-Related Disorders
Keywords
Cocaine Dependence, Selegiline
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
50 (Actual)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
Selegiline
Primary Outcome Measure Information:
Title
Retention
Title
Cocaine use
Title
Cocaine craving
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Please contact site for information.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
James Cornish, M.D.
Organizational Affiliation
University of Pennsylvania
Official's Role
Principal Investigator
Facility Information:
Facility Name
PDVAMC Treatment Research Center
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19104
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Selegiline in Treatment of Cocaine Dependence - 2
We'll reach out to this number within 24 hrs